Loading…
Enhancing cell-mediated immunity through dendritic cell activation: the role of Tri-GalNAc-modified PLGA-PEG nanoparticles encapsulating SR717
M. Tuberculosis fusion proteins (TP) and the STING agonist SR717 are co-encapsulated within Triantennary N-Acetylgalactosamine (Tri-GalNAc)-modified PLGA-PEG nanoparticles, denoted as TP/GPS. Following subcutaneous administration, these TP/GPS are effectively phagocytosed by dendritic cells (DCs). T...
Saved in:
Published in: | Frontiers in immunology 2024-12, Vol.15 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c1654-60adc41bf3492c3a8ef3f3ea7ebf283cdf57e9a932927e7fb7f2b791154375b03 |
container_end_page | |
container_issue | |
container_start_page | |
container_title | Frontiers in immunology |
container_volume | 15 |
creator | Gong, Yang Jia, Hongbin Dang, Wenrui Zhou, Ting He, Pu Wang, Xiaolei Zhu, Bingdong |
description | M. Tuberculosis
fusion proteins (TP) and the STING agonist SR717 are co-encapsulated within Triantennary N-Acetylgalactosamine (Tri-GalNAc)-modified PLGA-PEG nanoparticles, denoted as TP/GPS. Following subcutaneous administration, these TP/GPS are effectively phagocytosed by dendritic cells (DCs). The encapsulated TP and SR717 are then released, stimulating the DCs maturation and antigen presentation to T cells. This leads to the subsequent activation and differentiation of CD4
+
and CD8
+
T cells into memory T cells. |
doi_str_mv | 10.3389/fimmu.2024.1490003 |
format | article |
fullrecord | <record><control><sourceid>pubmedcentral_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_d53fa54836a743449f04b893dfa03c00</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_d53fa54836a743449f04b893dfa03c00</doaj_id><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_11701044</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1654-60adc41bf3492c3a8ef3f3ea7ebf283cdf57e9a932927e7fb7f2b791154375b03</originalsourceid><addsrcrecordid>eNpV0d1q2zAYBmAzNljpegM70g04k_TJlrWTEUqWBcJatuxYfNZPomBLQXYKvYlec50fRnskIb16JPQWxVdGZwCN-uZD3x9nnHIxY0JRSuFDccPqWpTAufj4Zv65uBuG_ZSgQgFAdVO8LOIOowlxS4zrurJ3NuDoLDmZMYzPZNzldNzuiHXR5jAGcw4SNGN4wjGk-H2KOJJT50jyZJNDucTu99yUfbLBh8l6XC_n5eNiSSLGdMA8IZ0biIsGD8Oxm5Tp-r9_JJNfik8eu8HdXcfb4t_Pxeb-V7l-WK7u5-vSsLoSZU3RGsFaD0JxA9g4Dx4cStd63oCxvpJOoQKuuHTSt9LzVirGKgGyaincFquLaxPu9SGHHvOzThj0eSHlrb4-U9sKPFaigRqlACGUp6JtFFiPFAw9WT8u1uHYTt9nXBwzdu_Q9zsx7PQ2PWnGJGVUiEngF8HkNAzZ-f-HGdWnivW5Yn2qWF8rhlehF51K</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Enhancing cell-mediated immunity through dendritic cell activation: the role of Tri-GalNAc-modified PLGA-PEG nanoparticles encapsulating SR717</title><source>PubMed Central</source><creator>Gong, Yang ; Jia, Hongbin ; Dang, Wenrui ; Zhou, Ting ; He, Pu ; Wang, Xiaolei ; Zhu, Bingdong</creator><creatorcontrib>Gong, Yang ; Jia, Hongbin ; Dang, Wenrui ; Zhou, Ting ; He, Pu ; Wang, Xiaolei ; Zhu, Bingdong</creatorcontrib><description>M. Tuberculosis
fusion proteins (TP) and the STING agonist SR717 are co-encapsulated within Triantennary N-Acetylgalactosamine (Tri-GalNAc)-modified PLGA-PEG nanoparticles, denoted as TP/GPS. Following subcutaneous administration, these TP/GPS are effectively phagocytosed by dendritic cells (DCs). The encapsulated TP and SR717 are then released, stimulating the DCs maturation and antigen presentation to T cells. This leads to the subsequent activation and differentiation of CD4
+
and CD8
+
T cells into memory T cells.</description><identifier>ISSN: 1664-3224</identifier><identifier>EISSN: 1664-3224</identifier><identifier>DOI: 10.3389/fimmu.2024.1490003</identifier><language>eng</language><publisher>Frontiers Media S.A</publisher><subject>adjuvant ; dendritic cells ; Immunology ; PLGA-PEG nanoparticles ; SR717 ; Tri-GalNAc ; tuberculosis</subject><ispartof>Frontiers in immunology, 2024-12, Vol.15</ispartof><rights>Copyright © 2024 Gong, Jia, Dang, Zhou, He, Wang and Zhu 2024 Gong, Jia, Dang, Zhou, He, Wang and Zhu</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c1654-60adc41bf3492c3a8ef3f3ea7ebf283cdf57e9a932927e7fb7f2b791154375b03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11701044/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11701044/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27922,27923,53789,53791</link.rule.ids></links><search><creatorcontrib>Gong, Yang</creatorcontrib><creatorcontrib>Jia, Hongbin</creatorcontrib><creatorcontrib>Dang, Wenrui</creatorcontrib><creatorcontrib>Zhou, Ting</creatorcontrib><creatorcontrib>He, Pu</creatorcontrib><creatorcontrib>Wang, Xiaolei</creatorcontrib><creatorcontrib>Zhu, Bingdong</creatorcontrib><title>Enhancing cell-mediated immunity through dendritic cell activation: the role of Tri-GalNAc-modified PLGA-PEG nanoparticles encapsulating SR717</title><title>Frontiers in immunology</title><description>M. Tuberculosis
fusion proteins (TP) and the STING agonist SR717 are co-encapsulated within Triantennary N-Acetylgalactosamine (Tri-GalNAc)-modified PLGA-PEG nanoparticles, denoted as TP/GPS. Following subcutaneous administration, these TP/GPS are effectively phagocytosed by dendritic cells (DCs). The encapsulated TP and SR717 are then released, stimulating the DCs maturation and antigen presentation to T cells. This leads to the subsequent activation and differentiation of CD4
+
and CD8
+
T cells into memory T cells.</description><subject>adjuvant</subject><subject>dendritic cells</subject><subject>Immunology</subject><subject>PLGA-PEG nanoparticles</subject><subject>SR717</subject><subject>Tri-GalNAc</subject><subject>tuberculosis</subject><issn>1664-3224</issn><issn>1664-3224</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpV0d1q2zAYBmAzNljpegM70g04k_TJlrWTEUqWBcJatuxYfNZPomBLQXYKvYlec50fRnskIb16JPQWxVdGZwCN-uZD3x9nnHIxY0JRSuFDccPqWpTAufj4Zv65uBuG_ZSgQgFAdVO8LOIOowlxS4zrurJ3NuDoLDmZMYzPZNzldNzuiHXR5jAGcw4SNGN4wjGk-H2KOJJT50jyZJNDucTu99yUfbLBh8l6XC_n5eNiSSLGdMA8IZ0biIsGD8Oxm5Tp-r9_JJNfik8eu8HdXcfb4t_Pxeb-V7l-WK7u5-vSsLoSZU3RGsFaD0JxA9g4Dx4cStd63oCxvpJOoQKuuHTSt9LzVirGKgGyaincFquLaxPu9SGHHvOzThj0eSHlrb4-U9sKPFaigRqlACGUp6JtFFiPFAw9WT8u1uHYTt9nXBwzdu_Q9zsx7PQ2PWnGJGVUiEngF8HkNAzZ-f-HGdWnivW5Yn2qWF8rhlehF51K</recordid><startdate>20241223</startdate><enddate>20241223</enddate><creator>Gong, Yang</creator><creator>Jia, Hongbin</creator><creator>Dang, Wenrui</creator><creator>Zhou, Ting</creator><creator>He, Pu</creator><creator>Wang, Xiaolei</creator><creator>Zhu, Bingdong</creator><general>Frontiers Media S.A</general><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20241223</creationdate><title>Enhancing cell-mediated immunity through dendritic cell activation: the role of Tri-GalNAc-modified PLGA-PEG nanoparticles encapsulating SR717</title><author>Gong, Yang ; Jia, Hongbin ; Dang, Wenrui ; Zhou, Ting ; He, Pu ; Wang, Xiaolei ; Zhu, Bingdong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1654-60adc41bf3492c3a8ef3f3ea7ebf283cdf57e9a932927e7fb7f2b791154375b03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>adjuvant</topic><topic>dendritic cells</topic><topic>Immunology</topic><topic>PLGA-PEG nanoparticles</topic><topic>SR717</topic><topic>Tri-GalNAc</topic><topic>tuberculosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gong, Yang</creatorcontrib><creatorcontrib>Jia, Hongbin</creatorcontrib><creatorcontrib>Dang, Wenrui</creatorcontrib><creatorcontrib>Zhou, Ting</creatorcontrib><creatorcontrib>He, Pu</creatorcontrib><creatorcontrib>Wang, Xiaolei</creatorcontrib><creatorcontrib>Zhu, Bingdong</creatorcontrib><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gong, Yang</au><au>Jia, Hongbin</au><au>Dang, Wenrui</au><au>Zhou, Ting</au><au>He, Pu</au><au>Wang, Xiaolei</au><au>Zhu, Bingdong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Enhancing cell-mediated immunity through dendritic cell activation: the role of Tri-GalNAc-modified PLGA-PEG nanoparticles encapsulating SR717</atitle><jtitle>Frontiers in immunology</jtitle><date>2024-12-23</date><risdate>2024</risdate><volume>15</volume><issn>1664-3224</issn><eissn>1664-3224</eissn><abstract>M. Tuberculosis
fusion proteins (TP) and the STING agonist SR717 are co-encapsulated within Triantennary N-Acetylgalactosamine (Tri-GalNAc)-modified PLGA-PEG nanoparticles, denoted as TP/GPS. Following subcutaneous administration, these TP/GPS are effectively phagocytosed by dendritic cells (DCs). The encapsulated TP and SR717 are then released, stimulating the DCs maturation and antigen presentation to T cells. This leads to the subsequent activation and differentiation of CD4
+
and CD8
+
T cells into memory T cells.</abstract><pub>Frontiers Media S.A</pub><doi>10.3389/fimmu.2024.1490003</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1664-3224 |
ispartof | Frontiers in immunology, 2024-12, Vol.15 |
issn | 1664-3224 1664-3224 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_d53fa54836a743449f04b893dfa03c00 |
source | PubMed Central |
subjects | adjuvant dendritic cells Immunology PLGA-PEG nanoparticles SR717 Tri-GalNAc tuberculosis |
title | Enhancing cell-mediated immunity through dendritic cell activation: the role of Tri-GalNAc-modified PLGA-PEG nanoparticles encapsulating SR717 |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T12%3A05%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Enhancing%20cell-mediated%20immunity%20through%20dendritic%20cell%20activation:%20the%20role%20of%20Tri-GalNAc-modified%20PLGA-PEG%20nanoparticles%20encapsulating%20SR717&rft.jtitle=Frontiers%20in%20immunology&rft.au=Gong,%20Yang&rft.date=2024-12-23&rft.volume=15&rft.issn=1664-3224&rft.eissn=1664-3224&rft_id=info:doi/10.3389/fimmu.2024.1490003&rft_dat=%3Cpubmedcentral_doaj_%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_11701044%3C/pubmedcentral_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1654-60adc41bf3492c3a8ef3f3ea7ebf283cdf57e9a932927e7fb7f2b791154375b03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |